HOME >> BIOLOGY >> NEWS
ACS Weekly PressPac -- September 6, 2006

ies of 11 percent, whereas most new solar cells have efficiencies between 4 percent and 5 percent, according to Michael Graetzel, Ph.D., a chemist at the Swiss Federal Institute of Technology, Lausanne.

Graetzel's cells, which can be engineered into inexpensive, flexible sheets, could be used as coatings on glass windows to supply electric power to homes and businesses or as coatings on tents to supply power for soldiers in the field. The cells could be used in consumer applications within two to three years, the researcher says.

CONTACT: Michael Graetzel, Ph.D.
Swiss Federal Institute of Technology
Switzerland
Phone: 41-21-693-3112
Fax: 41-21-693-4111
e-mail: Michael.graetzel@epfl.ch


ARTICLE #3 EMBARGOED FOR: Sunday, Sept. 10, 5:30 p.m., EDT
'Conversation stoppers' fight deadly bacterial infections

NOTE: A press conference on this topic with call-in audio participation will be held at 10 a.m. Sept. 11. Reporters are asked to call five to ten minutes prior to the scheduled start time. Reporters will be asked to identify themselves, their affiliations and the topic of the briefing. Call 800-967-7140 (domestic); 719-457-2629 (international).

Bacterial infections are becoming more deadly worldwide due to increased resistance to antibiotics. Now Helen E. Blackwell and colleagues have developed a powerful strategy to fight these deadly infections: Instead of killing the bacteria directly, the scientists designed a group of compounds that can block the chemical signals that the bacteria use to communicate in an effort to stop their spread.

These compounds, small organic molecules that they call 'conversation stoppers,' could help deliver a powerful one-two punch to knock out deadly infections when combined with the killing power of antibiotics. In addition, these 'conversation stoppers' do not target bac
'"/>

Contact: Michael Woods
m_woods@acs.org
American Chemical Society
12-Sep-2006


Page: 1 2 3 4 5 6 7 8 9

Related biology news :

1. American Chemical Societys Weekly PressPac -- Aug. 8, 2007
2. American Chemical Societys Weekly PressPac -- Aug. 1, 2007
3. American Chemical Societys Weekly PressPac -- July 25, 2007
4. American Chemical Societys Weekly PressPac -- July 18, 2007
5. American Chemical Societys Weekly PressPac -- July 11, 2007
6. American Chemical Societys Weekly PressPac -- June 27/July 3, 2007
7. American Chemical Societys Weekly PressPac -- June 20, 2007
8. American Chemical Societys Weekly PressPac -- June 13, 2007
9. American Chemical Societys Weekly PressPac -- May 30, 2007
10. ACS News Service Weekly PressPac -- May 23, 2007
11. ACS News Service Weekly PressPac -- May 16, 2007

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/8/2017)... 7, 2017 The biometrics market has ... confluence of organizations, desires to better authenticate or ... (password and challenge questions), biometrics is quickly working ... The market is driven by use cases, though ... and enterprise uses cases, with consumer-facing use cases ...
(Date:2/7/2017)... , February 7, 2017 ... Global Solutions Corporation [OTC: IDGS], ("Ipsidy" or the "Company") ... electronic transaction processing services, is pleased to announce the ... Company. Effective January 31, 2017, Philip ... of Directors, CEO and President.  An experienced payment industry ...
(Date:2/2/2017)... Feb. 2, 2017   TapImmune, Inc. ... company specializing in the development of innovative peptide ... of cancer and metastatic disease, announced today it ... manufacturing of a second clinical lot of TPIV ... receptor alpha. The manufactured vaccine product will be ...
Breaking Biology News(10 mins):
(Date:2/18/2017)... Research and Markets has announced the addition of the ... offering. ... report provides separate comprehensive analytics for the US, Japan ... Annual estimates and forecasts are provided for the period 2015 through ... Market data and analytics are derived from primary and secondary research. ...
(Date:2/17/2017)... 17, 2017  Protagonist Therapeutics, Inc. (NASDAQ: PTGX) ... oral peptide drug candidates, PTG-100 and PTG-200, at ... Crohn,s and Colitis Organization (ECCO).  The ECCO congress ... from February 15 – 18, 2017. ... on Protagonist drug candidates PTG-100 and PTG-200. PTG-100, ...
(Date:2/16/2017)... BEACH, Fla. , Feb. 16, 2017 /PRNewswire/ ... company revolutionizing the development of liquid biopsy tests ... has entered into an exclusive license agreement with ... distribute MDNA,s proprietary liquid biopsy test for prostate ... South Korea . This is the ...
(Date:2/16/2017)... 16, 2017 Patient Care ... innovative telemedicine application, new and leading edge therapies ... a boom worldwide. The healthcare sector as whole ... services and new therapies for companies such as ... Cellectar Biosciences, Inc. (NASDAQ: CLRB ), ...
Breaking Biology Technology:
Cached News: